Clinical Trials Browser

Phase 1 × Thrombocythemia, Essential × poly ICLC × Clear all

NCT05025488 2025-04-06

Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm

Phase 1 Recruiting

Thrombocythemia, Essential, Primary Myelofibrosis